Seetha Lakshmanan

Dr. Seetha Lakshmanan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Cureus
Verified
Journal Article
Open access
PDF file
SLSeetha Lakshmanan
Seetha Lakshmanan
AMAmer Malik
Amer Malik
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a global health crisis. This virus uses angiotensin converting enzyme 2 (ACE2) receptors to facilitate cellular entry. ACE2 receptors appear to be highly expressed in pancreatic exocrine glands and islet cells, more so than in lung tissues, suggesting that pancreatic injury can occur despite having only mild COVID-19 symptoms. We report a patient with COVID-19 who presented with only gastrointestinal symptoms and discuss the importance of identifying pancreatitis early to improve prognosis.

13 September 2020 in Cureus
Verified
Journal Article
Open access
PDF file
SDSaravgunjit Singh Daid
Saravgunjit Singh Daid
ATAdderly D. Toribio
Adderly D. Toribio
SLSeetha Lakshmanan
Seetha Lakshmanan
ASAyad Sadda
Ayad Sadda
AEAlan Epstein
Alan Epstein
Patients with coronavirus disease 2019 (COVID-19) have been presenting with varying signs and symptoms. The medical community is being updated with new knowledge about this disease daily. We present a case of intrahepatic hemorrhage in a patient diagnosed with C0VID-19 which we believe was caused by endothelialitis, which is a characteristic feature of COVID-19. Nevertheless, further continued studies are required to validate this point. We aim to educate the medical community about the possible complications by COVID-19 in the liver and highlight that N-acetylcysteine (NAC) may be a useful option in these cases.

14 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSeetha Lakshmanan
Seetha Lakshmanan
NTNicolas R. Thompson
Nicolas R. Thompson
Maeve PascoeMaeve Pascoe
Maeve Pascoe
RMReena Mehra
Reena Mehra
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
HWHarneet Walia
Harneet Walia
Study Objective: Studies have shown increased prevalence of restless legs syndrome (RLS) in sleep disordered breathing (SDB), however limited data have focused on the impact of SDB therapy on RLS. We hypothesize that positive airway pressure (PAP) will improve the International Restless Legs Syndrome (IRLS) score among SDB patients compared to patients without PAP. Methods: Patients with AHI ≥ 5 who responded positively to a RLS qualifier question from January 2010 to May 2015 were included in this retrospective study. IRLS score was used to measure RLS symptom severity. Two-sample t-tests and one-way analysis of variance were used to compare changes in IRLS score and linear regression models were created to examine IRLS change with PAP use and PAP adherence (PAP usage ≥4 h nightly for ≥70% of nights), adjusting for potential confounders. Results: In 434 patients (51.9 ± 13.4years, 50.5% female, 77.6% Caucasian; 325 PAP, 109 control), IRLS scores improved from baseline to follow-up, with the PAP group achieving significant improvement after adjustment for covariates (difference in IRLS: −1.8 (CI −3.6,0.00), p = 0.050). In self-reported PAP adherent patients, IRLS improvement was greater than controls (−5.3 ± 7.4 vs. −2.7 ± 7.6 respectively, p = 0.045), and comparable to non-adherent patients (−5.3 ± 7.4 vs. −3.0 ± 7.0, p = 0.091). Conclusions: Among SDB patients with a positive RLS qualifier, those who used PAP therapy achieved significantly greater improvement in IRLS scores than patients who did not use PAP, with more significant changes in the PAP adherent group. This is the first large clinical study to examine these relationships, providing a basis for future prospective interventional trials and informing clinicians of expected improvement in IRLS score in PAP treated SDB populations.

1 January 2022 in Journal of Women's Health
Verified
Journal Article
Closed access
SLSeetha Lakshmanan
Seetha Lakshmanan
SKSunanda Kane
Sunanda Kane
CDChristy Dibble
Christy Dibble
BRBani Roland
Bani Roland
Women's gastrointestinal (GI) health is a topic that is not well understood nor taught in most training programs. In this article, we highlight the importance of proper training in women's GI health among gastroenterologists and fellows, and identify some common conditions to provide the best possible treatment for their female patients.

29 July 2020 in Cureus
Verified
Journal Article
Open access
PDF file
YMYashvin Onkarappa Mangala
Yashvin Onkarappa Mangala
SDSaravgunjit Singh Daid
Saravgunjit Singh Daid
SLSeetha Lakshmanan
Seetha Lakshmanan
RKRahul Kapil
Rahul Kapil
JMJohn Miskovsky
John Miskovsky
Coronavirus disease 2019 (COVID-19), which is currently causing a global pandemic, is found to be associated with abnormal coagulation parameters and hyper-coagulable state with increased risk of venous thromboembolism (VTE). Here, we present two non-ICU cases of COVID-19, complicated with acute pulmonary embolism (PE). As of now, there are no proper guidelines established on anticoagulation in these patients. We discuss the pathophysiology and management strategy based on recently published studies on anticoagulation in COVID-19 patients.

23 July 2020 in Cureus
Verified
Journal Article
Open access
PDF file
SLSeetha Lakshmanan
Seetha Lakshmanan
DBDhanya Baskaran
Dhanya Baskaran
YMYashvin Onkarappa Mangala
Yashvin Onkarappa Mangala
NTNabil Toubia
Nabil Toubia
Budd-Chiari syndrome (BCS) occurs when there is hepatic venous outflow obstruction. Chronic BCS may result in liver cirrhosis due to long-standing obstruction and tend to present late. We present the first case of BCS secondary to Janus tyrosine kinase 2 (JAK2) mutation resulting in "pseudocirrhosis" rather than cirrhosis of the liver. Pseudocirrhosis clinically and radiologically mimics cirrhosis without the classical histopathological changes, and it is usually associated with metastatic cancers.